Understanding OUR Cytokine-Based Immunotherapy Candidates Our determination extends to advancing a robust portfolio of programs targeted at expanding the horizons of cytokine-based immunotherapy, specifically for cancers where cure possibilities remain limited. Use the links below to learn more about our portfolio of cytokine-based immunotherapy candidates. Examine Our Pipeline We're https://financefeeds.com/canadian-investors-rush-idegen-as-listing-nears/